Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 195691, 12 pages
http://dx.doi.org/10.1155/2013/195691
Clinical Study

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

1Biotherapeutic Department, Chinese PLA General Hospital, Beijing 100853, China
2Department of Cadre Health Care, Naval General Hospital, Beijing 100048, China

Received 30 September 2013; Accepted 13 November 2013

Academic Editor: Eyad Elkord

Copyright © 2013 Yajing Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [18 citations]

The following is the list of published articles that have cited the current article.

  • Zheng-Xu Wang, Jun-Li Li, Jun-Xia Cao, Yi-Shan Liu, Duo Li, Xiao-Yan Zhang, Min Wang, Min Wu, Bei-Lei Xu, Jin-Long Liu, and Hai-Bo Wang, “Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis,” Immunotherapy, vol. 6, no. 6, pp. 787–795, 2014. View at Publisher · View at Google Scholar
  • Ji Sung Kim, In Sung Chung, Sang Hee Lim, Yunsoo Park, Mi Jeong Park, Ju Young Kim, Yong Guk Kim, Jin Tae Hong, Youngsoo Kim, and Sang-Bae Han, “Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma,” Archives of Pharmacal Research, 2014. View at Publisher · View at Google Scholar
  • Yajing Zhang, Lei Xia, Yan Zhang, Yao Wang, Xuechun Lu, Fengxia Shi, Yang Liu, Meixia Chen, Kaixhao Feng, Wenying Zhang, Xiaobing Fu, and Weidong Han, “Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers,” Expert Opinion on Biological Therapy, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Qun Gao, Fei Wang, Liping Wang, Li Yang, Zhen Zhang, Dongli Yue, Meng Wang, and Yi Zhang, “Effects of different cell culture medium and different sources of serum on proliferative and functional activities of cytokine-induced killer cells,” Chinese Journal of Cancer Biotherapy, vol. 21, no. 6, pp. 680–686, 2014. View at Publisher · View at Google Scholar
  • Hui Fan, Xuechun Lu, Xiaohui Wang, Yang Liu, Bo Guo, Yan Zhang, Wenying Zhang, Jing Nie, Kaichao Feng, Meixia Chen, Yajing Zhang, Yao Wang, Fengxia Shi, Xiaobing Fu, Hongli Zhu, and Weidong Han, “Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report,” Journal of Immunology Research, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Yelei Guo, and Weidong Han, “Cytokine-induced killer (CIK) cells: from basic research to clinical translation,” Chinese Journal of Cancer, vol. 34, no. 1, pp. 6, 2015. View at Publisher · View at Google Scholar
  • Sarah Oelsner, Juliane Wagner, Miriam E. Friede, Verena Pfirrmann, Sabrina Genßler, Eva Rettinger, Christian J. Buchholz, Heike Pfeifer, Ralf Schubert, Oliver G. Ottmann, Evelyn Ullrich, Peter Bader, and Winfried S. Wels, “Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival,” International Journal of Cancer, vol. 139, no. 8, pp. 1799–1809, 2016. View at Publisher · View at Google Scholar
  • Hejin Jia, Yaping Tian, Chao Guang Jiang, and Weidong Han, “Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemother,” Experimental And Therapeutic Medicine, vol. 11, no. 5, pp. 1601–1610, 2016. View at Publisher · View at Google Scholar
  • Huiping Huo, Junlai Li, Guangzhi He, Chenhong Zheng, Huiming Zhang, Zhiquan Zhu, and Hongpeng Zhang, “TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis,” International Immunopharmacology, vol. 40, pp. 436–442, 2016. View at Publisher · View at Google Scholar
  • Ana P. S. Silva, Priscila V. Coelho, Maristella Anazetti, and Patricia U. Simioni, “Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors,” Human Vaccines & Immunotherapeutics, vol. 13, no. 4, pp. 843–853, 2016. View at Publisher · View at Google Scholar
  • L. Ma, Y. Wang, J. Bo, W. Han, Y. Wang, L. Zhang, X. Wu, S. Yu, and R. Liu, “Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome,” Clinical & Experimental Immunology, vol. 184, no. 1, pp. 83–89, 2016. View at Publisher · View at Google Scholar
  • Qian Long, Hang Zhou, Jiahui Wang, Yuan Feng, Ling Huang, Xing Zhou, and Jun Chen, “Efficacy of cytokine-induced killer cells on patients with advanced lung cancer,” Chinese Journal of Clinical Oncology, vol. 43, no. 7, pp. 302–305, 2016. View at Publisher · View at Google Scholar
  • Chunlei Ge, Ruilei Li, Xin Song, and Shukui Qin, “Advances in evidence-based cancer adoptive cell therapy,” Chinese Clinical Oncology, vol. 6, no. 2, pp. 1–18, 2017. View at Publisher · View at Google Scholar
  • Je Il Ryu, Myung Hoon Han, Jin Hwan Cheong, Jae Min Kim, and Choong Hyun Kim, “Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas,” Immunotherapy, vol. 9, no. 5, pp. 411–421, 2017. View at Publisher · View at Google Scholar
  • Armin Hirbod-Mobarakeh, Hesam Addin Gordan, Zahra Zahiri, Mohammad Mirshahvalad, Sima Hosseinverdi, Brian I. Rini, and Nima Rezaei, “Specific immunotherapy in renal cancer: a systematic review,” Therapeutic Advances in Urology, vol. 9, no. 2, pp. 45–58, 2017. View at Publisher · View at Google Scholar
  • Yiming Meng, Zhifu Yu, Yefeng Wu, Tianzhao Du, Shi Chen, Fanjuan Meng, Nan Su, Yushu Ma, Xiaoxi Li, Sulan Sun, and Guirong Zhang, “Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application,” Human Vaccines & Immunotherapeutics, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Jianxin Hu, Junfeng Hu, Xiandong Liu, Chao Hu, Ming Li, and Wei Han, “Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer,” Medicine, vol. 96, no. 42, pp. e8310, 2017. View at Publisher · View at Google Scholar
  • Cindy Desmarais, Dagmar Riemann, Paolo Fornara, Barbara Seliger, Chiara Massa, Harlan Robins, and Corinna Fahldieck, “Identification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patients,” Oncotarget, vol. 8, no. 13, pp. 21212–21228, 2017. View at Publisher · View at Google Scholar